Training Program in HIV Cure
Training Program in HIV Cure
批准号:
9203281
负责人:
Alan David Levine
金额:
$22.76万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-07-01 至 2021-06-30
关键词:
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The goal of this Training Program in HIV Cure (TPHC) is to provide outstanding training in basic, translational,
and clinical research toward the HIV Cure agenda to outstanding predoctoral students and highly qualified MD
or PhD postdoctoral fellows. The program includes 14 trainers and 8 junior trainers from 8 PhD programs, 11
departments in the School of Medicine, the Lerner College of Medicine, School of Dental Medicine, and the
College of Arts and Sciences at Case Western Reserve University, and 9 clinical units at both University
Hospitals (UH) Case Medical Center, the Louis Stokes Cleveland VA Medical Center, and the Cleveland Clinic
Foundation, and is closely allied with the Case/UH Center for AIDS Research (CFAR). The participating 14
senior faculty is known for excellence in research, ample NIH and foundation funding, and robust research
space, and have been specifically selected from a very large complement of excellent CFAR members to
provide focus toward the single goal of curing an HIV infection in the periphery, the mucosa, and the brain. To
expand the diversity of our trainers and to look to the future, we have also recruited 8 junior faculty, with strong
developing programs who have not yet trained many investigators, yet will develop into outstanding preceptors
through our co-mentoring program. Training focuses on relating the basic approaches of molecular and cellular
virology, genomics, proteomics and systems biology, immunology, and clinical dissection of non-AIDS
complications to mechanistic questions and solutions that address viral reservoirs, persistence, latency,
immune exhaustion, systemic inflammation, and immune control, with particular emphasis on (a) Viral
transcriptional regulation, (b) Host restriction factors, (c) Viral replication and reservoirs, (d) Systemic and
mucosal immunity, (e) Clinical trials, (f) Signal transduction and gene expression, and (g) Systems biology and
bioinformatics. Predoctoral training is accomplished through enrollment of students who have matriculated in
the 8 PhD programs in Molecular Virology, Cell Biology, Immunology, Systems Biology and Bioinformatics,
Chemistry, Doctorate of Nursing Practice, Molecular Medicine, and Epidemiology and Biostatistics. The basic
coursework and guided training in research skills provided by these departmental programs in the three
schools on the Health Sciences Campus, at the Lerner College of Medicine in the Cleveland Clinic Foundation,
and in the College of Arts and Sciences, is supplemented and enhanced by TPHC-specific components.
Postdoctoral trainees, who are appointed via their recruitment to a TPHC trainer’s lab as well as the CFAR, will
also participate in the following programmatic and career development activities:
(i) Completion of an additional, required graduate course in the Clinical Research Scholars Program
(CRSP) at CWRU [http://casemed.case.edu/crsp]
(ii) Participation in an exciting Clinical Immersion Experience in HIV clinical care at the University
Hospitals Special Immunology Unit, the Louis Stokes Cleveland VA Medical Center, or the HIV
Section of the Department of Infectious Diseases at the Cleveland Clinic Foundation
(iii) Representation of the University on the Cleveland HIV Community Action Board
(iv) International travel to Kampala, Uganda to interact with patients, scientists, and clinicians at the
Joint Clinical Research Center [http://www.jcrc.org.ug], a Center of of Excellence that was started
by H.E. President Yoweri Museveni in 1990 to address the very serious problem of HIV/AIDS in
Africa
(v) Establishing a CFAR-sponsored research working team with other TPHC trainees and the Fogarty
trainees from Uganda on the CWRU campus
(vi) Guest oral presentations at the CFAR internal and external annual retreats, in addition to the
weekly seminar series and monthly journal club, organized by the CFAR, the Center for Global
Health, the Division of Infectious Diseases, the Department of Molecular Biology and Microbiology,
the Immunology Training Program, and the Molecular Medicine Program at the CCF
(vii) Mentoring by a TPHC faculty committee that includes senior trainers and junior trainer faculty who
are developing independent programs in cutting-edge areas of HIV Cure research
This application seeks 4 positions (2 predocs and 2 mid-career PhD or MD postdocs per year).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pilot Research Project Core E
-
批准号:10632102
-
项目类别:
-
资助金额:$32.01万
-
财政年份:2021
-
负责人:Alan David Levine
-
依托单位:
Pilot Research Project Core E
-
批准号:10304587
-
项目类别:
-
资助金额:$32.01万
-
财政年份:2021
-
负责人:Alan David Levine
-
依托单位:
Administrative Core A
-
批准号:10632090
-
项目类别:
-
资助金额:$69.74万
-
财政年份:2021
-
负责人:Alan David Levine
-
依托单位:
CWRU Center for Excellence on the Impact of Substance Use on HIV
-
批准号:10632089
-
项目类别:
-
资助金额:$321.57万
-
财政年份:2021
-
负责人:Alan David Levine
-
依托单位:
Administrative Core A
-
批准号:10304583
-
项目类别:
-
资助金额:$69.74万
-
财政年份:2021
-
负责人:Alan David Levine
-
依托单位:
CWRU Center for Excellence on the Impact of Substance Use on HIV
-
批准号:10570441
-
项目类别:
-
资助金额:$7.9万
-
财政年份:2021
-
负责人:Alan David Levine
-
依托单位:
CWRU Center for Excellence on the Impact of Substance Use on HIV
-
批准号:10304582
-
项目类别:
-
资助金额:$319.58万
-
财政年份:2021
-
负责人:Alan David Levine
-
依托单位:
CWRU Center for Excellence on the Impact of Substance Use on HIV
-
批准号:10754712
-
项目类别:
-
资助金额:$7.9万
-
财政年份:2021
-
负责人:Alan David Levine
-
依托单位:
Identification of immune protective pathways dysregulated by opioid use in HIV infection, using a systems biology-based approach, toward the goal of pharmacological restoration of immune function
-
批准号:9927835
-
项目类别:
-
资助金额:$7.06万
-
财政年份:2016
-
负责人:Alan David Levine
-
依托单位:
Identification of immune protective pathways dysregulated by opioid use in HIV infection, using a systems biology-based approach, toward the goal of pharmacological restoration of immune function
-
批准号:10398591
-
项目类别:
-
资助金额:$1.42万
-
财政年份:2016
-
负责人:Alan David Levine
-
依托单位:
Identification of immune protective pathways dysregulated by opioid use in HIV infection, using a systems biology-based approach, toward the goal of pharmacological restoration of immune function
-
批准号:9712238
-
项目类别:
-
资助金额:$6.47万
-
财政年份:2016
-
负责人:Alan David Levine
-
依托单位:
Identification of immune protective pathways dysregulated by opioid use in HIV infection, using a systems biology-based approach, toward the goal of pharmacological restoration of immune function
-
批准号:9253661
-
项目类别:
-
资助金额:$81.38万
-
财政年份:2016
-
负责人:Alan David Levine
-
依托单位:
Identification of immune protective pathways dysregulated by opioid use in HIV infection, using a systems biology-based approach, toward the goal of pharmacological restoration of immune function
-
批准号:10171974
-
项目类别:
-
资助金额:$0.59万
-
财政年份:2016
-
负责人:Alan David Levine
-
依托单位:
Repairing the intestinal epithelium from the dual action of HIV and drug use
-
批准号:8759763
-
项目类别:
-
资助金额:$79.25万
-
财政年份:2015
-
负责人:Alan David Levine
-
依托单位:
Redox regulation of intestinal T cells
-
批准号:7707850
-
项目类别:
-
资助金额:$19.63万
-
财政年份:2009
-
负责人:Alan David Levine
-
依托单位:
Extracellular Matrix in Inflammatory Bowel Disease
-
批准号:7925821
-
项目类别:
-
资助金额:$34.25万
-
财政年份:2009
-
负责人:Alan David Levine
-
依托单位:
Extracellular Matrix in Inflammatory Bowel Disease
-
批准号:7741313
-
项目类别:
-
资助金额:$36.32万
-
财政年份:2009
-
负责人:Alan David Levine
-
依托单位:
Redox regulation of intestinal T cells
-
批准号:7924138
-
项目类别:
-
资助金额:$23.55万
-
财政年份:2009
-
负责人:Alan David Levine
-
依托单位:
Identification and Regulation of Defensins in Human Mucosal Tissue
-
批准号:7667143
-
项目类别:
-
资助金额:$4.73万
-
财政年份:2008
-
负责人:Alan David Levine
-
依托单位:
Mucosal T Cells: Is Tolerance Floating on Lipid Rafts
-
批准号:6695284
-
项目类别:
-
资助金额:$26.78万
-
财政年份:2003
-
负责人:Alan David Levine
-
依托单位:
海外基金